NeuroOne Medical Technologies Corp. (NMTC)
0.95
-0.03
(-3.44%)
USD |
NASDAQ |
Oct 21, 09:56
NeuroOne Medical Technologies Net Income (Quarterly) : -2.006M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.006M |
| March 31, 2026 | -2.382M |
| December 31, 2025 | -1.438M |
| September 30, 2025 | -1.619M |
| June 30, 2025 | -1.501M |
| March 31, 2025 | -2.271M |
| December 31, 2024 | 1.785M |
| September 30, 2024 | -3.351M |
| June 30, 2024 | -2.768M |
| March 31, 2024 | -2.855M |
| December 31, 2023 | -3.345M |
| September 30, 2023 | -3.135M |
| June 30, 2023 | -3.469M |
| March 31, 2023 | -3.523M |
| December 31, 2022 | -1.733M |
| September 30, 2022 | -1.374M |
| June 30, 2022 | -2.760M |
| March 31, 2022 | -3.058M |
| December 31, 2021 | -2.808M |
| September 30, 2021 | -2.643M |
| June 30, 2021 | -2.952M |
| March 31, 2021 | -2.394M |
| December 31, 2020 | -1.960M |
| September 30, 2020 | -0.5664M |
| June 30, 2020 | -7.091M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.346M |
| December 31, 2019 | -4.637M |
| September 30, 2019 | -1.354M |
| June 30, 2019 | -1.863M |
| March 31, 2019 | -2.212M |
| December 31, 2018 | -1.353M |
| September 30, 2018 | -4.209M |
| June 30, 2018 | -1.261M |
| March 31, 2018 | -1.357M |
| December 31, 2017 | -1.625M |
| September 30, 2017 | -1.409M |
| June 30, 2017 | -0.0236M |
| March 31, 2017 | -0.0088M |
| December 31, 2016 | -0.0084M |
| September 30, 2016 | -0.0056M |
| June 30, 2016 | -0.0141M |
| March 31, 2016 | -0.0044M |
| December 31, 2015 | -0.0088M |
| September 30, 2015 | -0.0026M |
| June 30, 2015 | -0.0221M |
| March 31, 2015 | -0.0116M |
| December 31, 2014 | -0.0099M |
| September 30, 2014 | -0.0061M |
| June 30, 2014 | -0.016M |
| March 31, 2014 | -0.0042M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
| Baxter International, Inc. | 135.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.973M |
| Total Expenses (Quarterly) | 3.979M |
| EPS Diluted (Quarterly) | -0.2754 |
| Enterprise Value | 6.690M |
| Gross Profit Margin (Quarterly) | 59.94% |
| Profit Margin (Quarterly) | -101.7% |
| Earnings Yield | -97.03% |
| Normalized Earnings Yield | -99.56 |